Skip to content
HomeLatest newsHealth & wellnessMade in the shade: A new study looks at why a beach umbrella and high SPF sunscreen could be a good combo
JAMA Sunscreen Image

Made in the shade: A new study looks at why a beach umbrella and high SPF sunscreen could be a good combo

Have these dark and dreary winter days inspired you to plan a trip to the Caribbean? Before you make a beeline for that beach umbrella, don’t forget to apply some high SPF sunscreen.

According to a Johnson & Johnson study recently published in JAMA Dermatology, researchers found that sitting in the shade alone doesn’t adequately protect your skin from the sun’s harmful UV rays. Study participants who spent 3.5 hours on a sunny beach were divided into two groups: One sat under a beach umbrella with no other sun protection; the other applied SPF 100+ sunscreen, without any umbrella coverage.

Afterwards, 78% of people in the umbrella group showed signs of sunburn versus just 25% in the sunscreen group, suggesting that the sunscreen offered significantly better protection.

“Umbrella shade alone may not provide sufficient protection for extended sun exposure,” says the study’s lead author Hao Ou-Yang, Ph.D., Manager, Medical Research, R&D Fellow, Johnson & Johnson. “Although using SPF 100 was better than simply sitting in the shade, neither prevents sunburn completely. That’s why it’s essential to use a combination of sun protection methods.”

So when you get to the beach (or sit outside anywhere on a bright day), opt for multiple forms of protection—such as sunscreen, shade and hats—and then crack open a novel and order that fruity drink.

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.